Thus, in vitro experiments have shown that IFN-β treatment induced CXCL10 expression of melanoma cells [58] and DCs stimulated with IFNα/IFN-β produced significant amounts of CXCL9 and CXCL10 [41]. The gene discussed is CXCL10; the disease is melanoma.